Aphria Introduces CannRelief, a CBD-based Nutraceutical and Cosmetics Product Line, for the German Market

Published: April 2, 2019

Aphria Introduces CannRelief, a CBD-based Nutraceutical and Cosmetics Product Line, for the German Market

Aphria Inc. through its subsidiary Aphria Deutschland GmbH launched the Company’s first CBD-based nutraceutical, the first product in its CBD-based cosmetics line for the German market. Featuring CBD derived from hemp, the CannRelief brand of products are being produced in the European Union and distributed by the Company’s subsidiary, CC Pharma, which has access to more than 13,000 pharmacies throughout Germany.

“We are excited to introduce our first brand of CBD products for the German nutraceutical and cosmetics market,” said Jakob Ripshtein, President of Aphria. “Supported by our extensive distribution network through CC Pharma, CannRelief provides a natural extension to Aphria’s growing business opportunities in the German medical cannabis market. We look forward to providing a full range of CannRelief CBD products this year.”

CannRelief CBD oils are being sold in both a 5% and 10% CBD concentration and can be found in select stores across Germany. A range of skincare and other products, including creams, serums and masks will be introduced under the CannRelief brand in a phased rollout in 2019. More information about CannRelief products can be found at cannrelief.de.

“Aphria continues to execute on its strategic growth initiatives in Germany,” continued Ripshtein. “We believe we have tremendous momentum in Germany and across our international business as we continue to strengthen our global footprint.”